These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1142 related items for PubMed ID: 17509946

  • 21. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study.
    Ohishi W, Fujiwara S, Cologne JB, Suzuki G, Akahoshi M, Nishi N, Takahashi I, Chayama K.
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):846-54. PubMed ID: 18398026
    [Abstract] [Full Text] [Related]

  • 22. Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.
    Lee MH, Yang HI, Lu SN, Jen CL, Yeh SH, Liu CJ, Chen PJ, You SL, Wang LY, Chen WJ, Chen CJ.
    J Clin Oncol; 2010 Oct 20; 28(30):4587-93. PubMed ID: 20855826
    [Abstract] [Full Text] [Related]

  • 23. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J.
    J Gastroenterol Hepatol; 2008 Mar 20; 23(3):459-66. PubMed ID: 17854425
    [Abstract] [Full Text] [Related]

  • 24. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
    Stroffolini T, Almasio PL, Persico M, Bollani S, Benvegnù L, Di Costanzo G, Pastore G, Aghemo A, Stornaiuolo G, Mangia A, Andreone P, Stanzione M, Mazzella G, Saracco G, Del Poggio P, Bruno S, Italian Association of the Study of the Liver Disease (AISF).
    Am J Gastroenterol; 2008 Aug 20; 103(8):1966-72. PubMed ID: 18637087
    [Abstract] [Full Text] [Related]

  • 25. Necessities of interferon therapy in elderly patients with chronic hepatitis C.
    Ikeda K, Arase Y, Kawamura Y, Yatsuji H, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Saitoh S, Suzuki F, Suzuki Y, Kumada H.
    Am J Med; 2009 May 20; 122(5):479-86. PubMed ID: 19375558
    [Abstract] [Full Text] [Related]

  • 26. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.
    Ito K, Tanaka Y, Orito E, Sugiyama M, Fujiwara K, Sugauchi F, Kato T, Tokita H, Izumi N, Kato M, Yuen MF, Lai CL, Gish RG, Ueda R, Mizokami M.
    Clin Infect Dis; 2006 Jan 01; 42(1):1-7. PubMed ID: 16323084
    [Abstract] [Full Text] [Related]

  • 27. Viral hepatitis and hepatocellular carcinoma.
    Marrero CR, Marrero JA.
    Arch Med Res; 2007 Aug 01; 38(6):612-20. PubMed ID: 17613352
    [Abstract] [Full Text] [Related]

  • 28. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
    Macías Rodríguez MA, Rendón Unceta P, Tejada Cabrera M, Infante Hernández JM, Correro Aguilar F, Díaz García F, Benítez Rodríguez E, Mangas Rojas A, Martín Herrera L.
    Rev Esp Enferm Dig; 2000 Jul 01; 92(7):458-69. PubMed ID: 11026763
    [Abstract] [Full Text] [Related]

  • 29. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C.
    Yamauchi M, Nakahara M, Maezawa Y, Satoh S, Nishikawa F, Ohata M, Mizuhara Y, Hirakawa J, Nakajima H, Fujisawa K.
    Am J Gastroenterol; 1993 Jan 01; 88(1):39-43. PubMed ID: 7678368
    [Abstract] [Full Text] [Related]

  • 30. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
    Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH.
    Korean J Hepatol; 2008 Mar 01; 14(1):67-76. PubMed ID: 18367859
    [Abstract] [Full Text] [Related]

  • 31. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K, Pal NS, Arora SK.
    Indian J Pathol Microbiol; 2006 Jul 01; 49(3):357-61. PubMed ID: 17001884
    [Abstract] [Full Text] [Related]

  • 32. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis.
    Pekow JR, Bhan AK, Zheng H, Chung RT.
    Cancer; 2007 Jun 15; 109(12):2490-6. PubMed ID: 17487861
    [Abstract] [Full Text] [Related]

  • 33. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C.
    Kramer JR, Giordano TP, Souchek J, Richardson P, Hwang LY, El-Serag HB.
    Am J Gastroenterol; 2005 Jan 15; 100(1):56-63. PubMed ID: 15654781
    [Abstract] [Full Text] [Related]

  • 34. Hepatitis B e antigen and the risk of hepatocellular carcinoma.
    Yang HI, Lu SN, Liaw YF, You SL, Sun CA, Wang LY, Hsiao CK, Chen PJ, Chen DS, Chen CJ, Taiwan Community-Based Cancer Screening Project Group.
    N Engl J Med; 2002 Jul 18; 347(3):168-74. PubMed ID: 12124405
    [Abstract] [Full Text] [Related]

  • 35. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.
    Scand J Gastroenterol; 2008 Jul 18; 43(7):849-56. PubMed ID: 18584524
    [Abstract] [Full Text] [Related]

  • 36. High viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Ohata K, Hamasaki K, Toriyama K, Ishikawa H, Nakao K, Eguchi K.
    J Gastroenterol Hepatol; 2004 Jun 18; 19(6):670-5. PubMed ID: 15151623
    [Abstract] [Full Text] [Related]

  • 37. Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients.
    Ohki T, Tateishi R, Sato T, Masuzaki R, Imamura J, Goto T, Yamashiki N, Yoshida H, Kanai F, Kato N, Shiina S, Yoshida H, Kawabe T, Omata M.
    Clin Gastroenterol Hepatol; 2008 Apr 18; 6(4):459-64. PubMed ID: 18387499
    [Abstract] [Full Text] [Related]

  • 38. Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B.
    Kubo S, Tanaka H, Shuto T, Takemura S, Yamamoto T, Kanazawa A, Uenishi T, Tanaka S, Hirohashi K, Nishiguchi S, Kinoshita H.
    Surg Today; 2005 Apr 18; 35(3):216-22. PubMed ID: 15772792
    [Abstract] [Full Text] [Related]

  • 39. Effect of alcohol, cigarette smoking, and diabetes on occurrence of hepatocellular carcinoma in patients with transfusion-acquired hepatitis C virus infection who develop cirrhosis.
    Di Costanzo GG, De Luca M, Tritto G, Lampasi F, Addario L, Lanza AG, Tartaglione MT, Picciotto FP, Ascione A.
    Eur J Gastroenterol Hepatol; 2008 Jul 18; 20(7):674-9. PubMed ID: 18679071
    [Abstract] [Full Text] [Related]

  • 40. Changes in serum levels of HBV DNA and alanine aminotransferase determine risk for hepatocellular carcinoma.
    Chen CF, Lee WC, Yang HI, Chang HC, Jen CL, Iloeje UH, Su J, Hsiao CK, Wang LY, You SL, Lu SN, Chen CJ, Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer in HBV (REVEAL–HBV) Study Group.
    Gastroenterology; 2011 Oct 18; 141(4):1240-8, 1248.e1-2. PubMed ID: 21703214
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 58.